• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Clinical Trials, Drugs (Pharmaceuticals), Eli Lilly and Company, GLP-1 RAs (Drug), Obesity, Research
←Cannonball with Wesley Morris: Beyoncé Isn’t Giving Up on America
The Trump-Backed Federal Budget Threatens Black Economic Progress. Here’s How Black Communities Can Reclaim Their Power→

More posts

  • Stephen Colbert Just Spotted Rock-Solid Proof Trump’s Life “Isn’t Going Great” Right Now, And It’s Something Everyone Needs To See

  • Relish and dread as Starmer ‘shambles’ hangs over Scotland and Wales elections

  • In Wine Country, Sales Are Down and Fraud is Rampant

  • Black Wealth Watch: Black Wealth Watch: Cardi B’s Haircare Sells Out In Minutes, Pat McGrath Steps Down As CEO, And The Obamas Exit Netflix Deal

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube